ERBB2 and metastasis: As shown in Table 3, a statistically significant difference was observed between HER-2 positivity/negativity and the variables of sex (p = 0.017), pathological subtype (p = 0.010), liver metastasis (p = 0.007), lung metastasis (p = 0.004), and other metastases (p = 0.004).